Pharma Two B Ltd.

Industry

  • Pharmaceuticals
    • Generic Drugs
    • Drug Delivery
      • Controlled Release
    • Specialty Pharmaceuticals
See more in Biomedtracker

Latest on Pharma Two B Ltd.

Scrip

Deal Watch: BI Acquires Nerio For Novel Immune Checkpoint Inhibitor

 
• By Joseph Haas and Mary Jo Laffler

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Boehringer Ingelheim Acquires Nerio The

Scrip

Asia Deal Watch: Astellas Looks To Next-Gen AAV Vectors Despite Gene Therapy Clinical Setbacks

 
• By Ian Haydock, Anju Ghangurde, Dexter Jie Yan, Jung Won Shin, and Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Astellas, Dyno Sign Deal On Next-Gen AA

Scrip

Patience Pays Off For Kyowa Kirin As Nourianz Finally Gets US FDA OK

 
• By Mandy Jackson

Kyowa Kirin Co. Ltd. never gave up on Nourianz (istradefylline) for Parkinson's disease (PD) and now the company's patience has paid off with US Food and Drug Administration approval on 28 August for

Scrip

Pipeline Watch: Peficitinib, Ubrogepant, Apalutamide Phase III Read-Outs

 
• By John Davis

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer